Extensive phase 1 clinical trial evaluates safety of treatment among peritoneal patients

Candidate POLB 001 demonstrates potential in treating multiple influenza conditions

European Medicines Agency has issued a positive opinion for the use of VLA2001 among certain adults

Pharma’s offer includes a yearly £1bn boost to the NHS and a new investment facility

The programme will support new European and national strategies to reduce exposure to hazardous chemicals

Understanding how the knee joint environment affects cartilage cells is crucial for joint health. Knowledge of cell-driven cartilage […]

Updated Date: Tue, 21 Feb 2023 00:00:00 EST

Updated Date: Tue, 21 Feb 2023 00:00:00 EST

Updated Date: Tue, 21 Feb 2023 00:00:00 EST

Updated Date: Tue, 21 Feb 2023 00:00:00 EST